Associations between national development indicators and the age profile of people who inject drugs: results from a global systematic review and meta-analysis

L. A. HINES ; A. TRICKEY ; J. LEUNG ; S. LARNEY ; A. PEACOCK ; L. DEGENHARDT ; S. COLLEDGE ; M. HICKMAN ; J. GREBELY ; E. B. CUNNINGHAM ; J. STONE ; K. DUMCHEV ; P. GRIFFITHS ; P. VICKERMAN ; R. P. MATTICK ; M. LYNSKEY | 2020
Dans Lancet Global Health (The) (Vol.8, n°1, January 2020) Article : Périodique

BACKGROUND: Globally, an estimated 15.6 million people inject drugs. We aimed to investigate global variation in the age profile of people who inject drugs (PWID), identify country-level factors associated with age of PWID, and assess the associ[...]

Plus d'info

Ajouter à la sélection

Lien externe

Combined treatment and prevention strategies for hepatitis C virus elimination in the prisons in New South Wales: a modelling study

N. A. BRETANA ; R. R. GRAY ; E. B. CUNNINGHAM ; B. BETZ-STABLEIN ; R. RIBEIRO ; F. GRAW ; F. LUCIANI ; A. R. LLOYD | 2020
Dans Addiction (Vol.115, n°5, May 2020) Article : Périodique

BACKGROUND AND AIMS: Australia is currently on track to meet the World Health Organization (WHO) global hepatitis C virus (HCV) elimination goals by 2030, reflecting universal subsidized access to testing and direct-acting antiviral (DAA) treatm[...]

Plus d'info

Ajouter à la sélection

Lien externe

Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review

L. DEGENHARDT ; P. WEBB ; S. COLLEDGE-FRISBY ; J. IRELAND ; A. WHEELER ; S. OTTAVIANO ; A. WILLING ; A. KAIROUZ ; E. B. CUNNINGHAM ; B. HAJARIZADEH ; J. LEUNG ; L. T. TRAN ; O. PRICE ; A. PEACOCK ; P. VICKERMAN ; M. FARRELL ; G. J. DORE ; M. HICKMAN ; J. GREBELY | 2023
Dans Lancet Global Health (The) (Vol.11, n°5, May 2023) Article : Périodique

BACKGROUND: People who inject drugs are exposed to various and changing risk environments and are at risk of multiple harms related to injecting drug use (IDU). We aimed to undertake a global systematic review of the prevalence of IDU, key IDU-r[...]

Plus d'info

Ajouter à la sélection

Lien externe

Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review

S. COLLEDGE-FRISBY ; S. OTTAVIANO ; P. WEBB ; J. GREBELY ; A. WHEELER ; E. B. CUNNINGHAM ; B. HAJARIZADEH ; J. LEUNG ; A. PEACOCK ; P. VICKERMAN ; M. FARRELL ; G. J. DORE ; M. HICKMAN ; L. DEGENHARDT | 2023
Dans Lancet Global Health (The) (Vol.11, n°5, May 2023) Article : Périodique

BACKGROUND: Harm reduction and treatment programmes are essential for reducing harms for people who inject drugs (PWID). We aimed to update estimates from a 2017 review of global coverage of needle and syringe exchange programmes (NSPs), opioid [...]

Plus d'info

Ajouter à la sélection

Lien externe

A global meta-analysis of the prevalence of HIV, hepatitis C virus, and hepatitis B virus among people who inject drugs - Do gender-based differences vary by country-level indicators?

J. LEUNG ; A. PEACOCK ; S. COLLEDGE ; J. GREBELY ; E. B. CUNNINGHAM ; M. HICKMAN ; P. VICKERMAN ; J. STONE ; A. TRICKEY ; K. DUMCHEV ; M. LYNSKEY ; L. HINES ; P. GRIFFITHS ; R. P. MATTICK ; L. DEGENHARDT ; S. LARNEY | 2019
Dans Journal of Infectious Diseases (Vol.220, n°1, July 2019) Article : Périodique

BACKGROUND: Women-specific factors exist that increases vulnerability to drug-related harms from injection drug use, including blood-borne viruses (BBVs), but gender-based differences in BBV prevalence have not been systematically examined. MET[...]

Plus d'info

Ajouter à la sélection

Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review

L. DEGENHARDT ; A. PEACOCK ; S. COLLEDGE ; J. LEUNG ; J. GREBELY ; P. VICKERMAN ; J. STONE ; E. B. CUNNINGHAM ; A. TRICKEY ; K. DUMCHEV ; M. LYNSKEY ; P. GRIFFITHS ; R. P. MATTICK ; M. HICKMAN ; S. LARNEY | 2017
Dans Lancet Global Health (The) (Vol.5, n°12, December 2017) Article : Périodique

Background: Sharing of equipment used for injecting drug use (IDU) is a substantial cause of disease burden and a contributor to blood-borne virus transmission. We did a global multistage systematic review to identify the prevalence of IDU among[...]

Plus d'info

Ajouter à la sélection

Lien externe

Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review

S. LARNEY ; A. PEACOCK ; J. LEUNG ; S. COLLEDGE ; M. HICKMAN ; P. VICKERMAN ; J. GREBELY ; K. V. DUMCHEV ; P. GRIFFITHS ; L. HINES ; E. B. CUNNINGHAM ; R. P. MATTICK ; M. LYNSKEY ; J. MARSDEN ; J. STRANG ; L. DEGENHARDT | 2017
Dans Lancet Global Health (The) (Vol.5, n°12, December 2017) Article : Périodique

Background: People who inject drugs (PWID) are a key population affected by the global HIV and hepatitis C virus (HCV) epidemics. HIV and HCV prevention interventions for PWID include needle and syringe programmes (NSP), opioid substitution ther[...]

Plus d'info

Ajouter à la sélection

Lien externe

Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs

J. GREBELY ; S. LARNEY ; A. PEACOCK ; S. COLLEDGE ; J. LEUNG ; M. HICKMAN ; P. VICKERMAN ; S. BLACH ; E. B. CUNNINGHAM ; K. DUMCHEV ; M. LYNSKEY ; J. STONE ; A. TRICKEY ; H. RAZAVI ; R. P. MATTICK ; M. FARRELL ; G. J. DORE ; L. DEGENHARDT | 2019
Dans Addiction (Vol.114, n°1, January 2019) Article : Périodique

BACKGROUND AND AIMS: People who have recently injected drugs are a priority population in efforts to achieve hepatitis C virus (HCV) elimination. This study estimated the prevalence and number of people with recent injecting drug use living with[...]

Plus d'info

Ajouter à la sélection

Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis

E. B. CUNNINGHAM ; A. WHEELER ; B. HAJARIZADEH ; C. E. FRENCH ; R. ROCHE ; A. D. MARSHALL ; G. FONTAINE ; A. CONWAY ; S. BAJIS ; B. M. VALENCIA ; J. PRESSEAU ; J. W. WARD ; L. DEGENHARDT ; G. J. DORE ; M. HICKMAN ; P. VICKERMAN ; J. GREBELY | 2023
Dans International Journal of Drug Policy (Vol.111, January 2023) Article : Périodique

Background: With the advent of direct acting antiviral (DAA) therapies for the treatment of hepatitis C virus (HCV), the World Health Organization recommended a goal to eliminate HCV as a public health threat globally by 2030. With the majority [...]

Plus d'info

Ajouter à la sélection

Lien externe

Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: A systematic review

S. BAJIS ; G. J. DORE ; B. HAJARIZADEH ; E. B. CUNNINGHAM ; L. MAHER ; J. GREBELY | 2017
Dans International Journal of Drug Policy (Vol.47, September 2017) Article : Périodique

Background: The burden of hepatitis C virus (HCV) infection is escalating among people who inject drugs (PWID), yet testing and treatment remains suboptimal. The aim of this systematic review was to evaluate the effectiveness of interventions to[...]

Plus d'info

Ajouter à la sélection

Interventions to reduce harms related to drug use among people who experience incarceration: systematic review and meta-analysis

C. MACDONALD ; G. MACPHERSON ; O. LEPPAN ; L. T. TRAN ; E. B. CUNNINGHAM ; B. HAJARIZADEH ; J. GREBELY ; M. FARRELL ; F. L. ALTICE ; L. DEGENHARDT | 2024
Dans Lancet Public Health (The) (Vol.9, n°9, September 2024) Article : Périodique

Background: Mortality, suicide, self-harm, and substance use are elevated among people who are incarcerated. There is a wide range of heterogeneous interventions aimed at reducing these harms in this population. Previous reviews have focused on [...]

Plus d'info

Ajouter à la sélection

Lien externe